EA201100757A1 - Способ приготовления гранулята действующих веществ и полученный таким способом гранулят - Google Patents

Способ приготовления гранулята действующих веществ и полученный таким способом гранулят

Info

Publication number
EA201100757A1
EA201100757A1 EA201100757A EA201100757A EA201100757A1 EA 201100757 A1 EA201100757 A1 EA 201100757A1 EA 201100757 A EA201100757 A EA 201100757A EA 201100757 A EA201100757 A EA 201100757A EA 201100757 A1 EA201100757 A1 EA 201100757A1
Authority
EA
Eurasian Patent Office
Prior art keywords
active substances
granules
granulate
preparing
preparing granulate
Prior art date
Application number
EA201100757A
Other languages
English (en)
Russian (ru)
Inventor
Кристоф Лёбон
Паскаль Сюпли
Original Assignee
Дебрежа Э Ассосье Фарма
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201100757(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Дебрежа Э Ассосье Фарма filed Critical Дебрежа Э Ассосье Фарма
Publication of EA201100757A1 publication Critical patent/EA201100757A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Glanulating (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201100757A 2008-11-14 2009-11-13 Способ приготовления гранулята действующих веществ и полученный таким способом гранулят EA201100757A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
PCT/FR2009/052180 WO2010055268A1 (fr) 2008-11-14 2009-11-13 Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus

Publications (1)

Publication Number Publication Date
EA201100757A1 true EA201100757A1 (ru) 2011-12-30

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100757A EA201100757A1 (ru) 2008-11-14 2009-11-13 Способ приготовления гранулята действующих веществ и полученный таким способом гранулят

Country Status (25)

Country Link
US (1) US20110280945A1 (enExample)
EP (1) EP2349226A1 (enExample)
JP (1) JP5608681B2 (enExample)
KR (1) KR101585705B1 (enExample)
CN (1) CN102223879A (enExample)
AR (1) AR074330A1 (enExample)
AU (1) AU2009315449B2 (enExample)
BR (1) BRPI0916019A2 (enExample)
CA (1) CA2743753A1 (enExample)
CL (1) CL2011001115A1 (enExample)
CO (1) CO6382108A2 (enExample)
CU (1) CU20110107A7 (enExample)
EA (1) EA201100757A1 (enExample)
FR (1) FR2938432B1 (enExample)
IL (1) IL212850A0 (enExample)
MA (1) MA32789B1 (enExample)
MX (1) MX2011005072A (enExample)
NZ (1) NZ592857A (enExample)
PE (1) PE20110945A1 (enExample)
SG (1) SG195651A1 (enExample)
TN (1) TN2011000235A1 (enExample)
TW (1) TWI522113B (enExample)
UA (1) UA103781C2 (enExample)
WO (1) WO2010055268A1 (enExample)
ZA (1) ZA201103543B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers
KR20240157168A (ko) * 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
PT1178778E (pt) * 1999-05-17 2006-06-30 D B F Granulos que contem uma substancia vegetal e o seu procedimento de preparacao
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
KR101468053B1 (ko) * 2006-08-31 2014-12-02 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물의 고용체를 포함하는 약물 전달 시스템
EP2110413B1 (en) * 2007-02-14 2013-03-20 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Dispersing agent for organic pigment and use thereof
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
CO6382108A2 (es) 2012-02-15
CU20110107A7 (es) 2012-01-31
NZ592857A (en) 2013-07-26
CN102223879A (zh) 2011-10-19
ZA201103543B (en) 2012-01-25
BRPI0916019A2 (pt) 2015-11-10
CL2011001115A1 (es) 2011-11-11
CA2743753A1 (fr) 2010-05-20
TWI522113B (zh) 2016-02-21
AU2009315449B2 (en) 2015-03-26
UA103781C2 (uk) 2013-11-25
EP2349226A1 (fr) 2011-08-03
FR2938432B1 (fr) 2011-05-20
SG195651A1 (en) 2013-12-30
JP2012508786A (ja) 2012-04-12
AR074330A1 (es) 2011-01-05
MA32789B1 (fr) 2011-11-01
US20110280945A1 (en) 2011-11-17
TW201029667A (en) 2010-08-16
PE20110945A1 (es) 2012-02-01
JP5608681B2 (ja) 2014-10-15
AU2009315449A1 (en) 2010-05-20
IL212850A0 (en) 2011-07-31
KR101585705B1 (ko) 2016-01-15
WO2010055268A1 (fr) 2010-05-20
MX2011005072A (es) 2011-10-03
TN2011000235A1 (fr) 2012-12-17
KR20110095888A (ko) 2011-08-25
FR2938432A1 (fr) 2010-05-21

Similar Documents

Publication Publication Date Title
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
EA201170742A1 (ru) Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламинов и их применения
EA200901157A1 (ru) Конденсированные кольцевые гетероциклические модуляторы киназы
FR2883179B1 (fr) Comprime enrobe
DK1896006T3 (da) Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet
EA201391318A1 (ru) Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение
EA200702586A1 (ru) Кристаллические модификации пираклостробина
EA201100758A1 (ru) Гранулят гамма-гидроксимасляной кислоты
WO2010007240A3 (fr) Granule-appat procede de fabrication
CL2008001897A1 (es) Proceso para la preparacion de 3-halometil-1-metil-1h-pirazol, utiles como intermediario en la produccion de fungicidas; compuestos derivados de 3-halometil-1-metil-1h-pirazol.
UY34210A (es) Composiciones, métodos y sistemas para la micropropagación de plantas
BR112012001048A2 (pt) Composições adjuvantes agrícolas, composições de pesticidas, e métodos de utilização de tais composições.
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA200970126A1 (ru) Способ получения прегабалина и его энантиомера
EA201100757A1 (ru) Способ приготовления гранулята действующих веществ и полученный таким способом гранулят
GEP20156396B (en) Adjuvant comprising dimethylsulfoxide and a phosphate ester
EA201390030A1 (ru) Способ получения препарата костного белка и препарат костного белка
HK1247125A1 (zh) 结晶化合物
WO2012017321A3 (en) Treatment for dyslipidemia
WO2009059712A3 (de) Homogene und lagerstabile mischungen unterschiedlicher pflanzenschutzmittel-wirkstoff-granulatpartikel
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
TW200621684A (en) Methods for the manufacture of biphenyl amines
MY152388A (en) Composition and method for controlling plant diseases
UA113977C2 (xx) Фармацевтична композиція з покращеною стабільністю
TR201003856A1 (tr) Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.